Corvus Pharmaceuticals Ownership 2024 | Who Owns Corvus Pharmaceuticals Now?
Institutional Ownership
3.58%
Insider Ownership
4.02%
Retail Ownership
92.40%
Institutional Holders
21.00
Corvus Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 14.16% | 0.25% | 6,943,654 | - | - | 12,637,450 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 12.49% | 0.19% | 6,123,021 | 3,774,658 | 160.74% | 11,143,898 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 12.16% | 0.03% | 5,964,510 | 5,964,510 | 100.00% | 10,855,408 | Jun 30, 2024 |
| ADAMS STREET PARTNERS LLC | 6.68% | 2.46% | 3,275,616 | - | - | 5,961,621 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.37% | 0.00% | 1,650,500 | 157,143 | 10.52% | 3,003,910 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.15% | 0.00% | 563,932 | -73,100 | -11.48% | 1,026,356 | Jun 30, 2024 |
| BLACKROCK INC. | 1.15% | - | 562,024 | 39,046 | 7.47% | 1,022,884 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.94% | 0.00% | 460,140 | 88,377 | 23.77% | 837,619 | Jun 30, 2024 |
| TOWERVIEW LLC | 0.82% | 0.48% | 400,000 | 17,500 | 4.58% | 728,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.76% | 0.00% | 371,403 | 96,042 | 34.88% | 675,954 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.42% | 0.00% | 204,598 | 181,317 | 778.82% | 372,368 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.26% | 0.01% | 127,300 | -97,000 | -43.25% | 231,686 | Jun 30, 2024 |
| STATE STREET CORP | 0.25% | - | 120,303 | - | - | 218,951,000 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.17% | 0.00% | 83,222 | -4,786 | -5.44% | 151,464 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.17% | - | 82,990 | 18,041 | 27.78% | 151,042,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.15% | 0.00% | 74,559 | 74,559 | 100.00% | 135,698 | Jun 30, 2024 |
| JACKSON SQUARE CAPITAL, LLC | 0.13% | 0.03% | 63,773 | - | - | 116,067 | Jun 30, 2024 |
| HIKARI POWER LTD | 0.10% | 0.01% | 49,959 | - | - | 91,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.10% | 0.00% | 47,786 | -54,663 | -53.36% | 86,971 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.05% | 0.00% | 24,364 | 24,364 | 100.00% | 44,342 | Jun 30, 2024 |
Corvus Pharmaceuticals's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 14.16% of the company's total share outstanding, currently valued at $12.64M. The top 10 institutional shareholders own together 53.66% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 6.68% | 2.46% | 3,275,616 | - | - | 5,961,621 | Jun 30, 2024 |
| TOWERVIEW LLC | 0.82% | 0.48% | 400,000 | 17,500 | 4.58% | 728,000 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 14.16% | 0.25% | 6,943,654 | - | - | 12,637,450 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 12.49% | 0.19% | 6,123,021 | 3,774,658 | 160.74% | 11,143,898 | Jun 30, 2024 |
| JACKSON SQUARE CAPITAL, LLC | 0.13% | 0.03% | 63,773 | - | - | 116,067 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 12.16% | 0.03% | 5,964,510 | 5,964,510 | 100.00% | 10,855,408 | Jun 30, 2024 |
| MASSO TORRENCE WEALTH MANAGEMENT INC. | 0.02% | 0.01% | 10,000 | - | - | 18,200 | Jun 30, 2024 |
| HIKARI POWER LTD | 0.10% | 0.01% | 49,959 | - | - | 91,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.26% | 0.01% | 127,300 | -97,000 | -43.25% | 231,686 | Jun 30, 2024 |
| QUINN OPPORTUNITY PARTNERS LLC | 0.05% | 0.00% | 22,327 | - | - | 40,635 | Jun 30, 2024 |
| NORTHWEST CAPITAL MANAGEMENT INC | 0.01% | 0.00% | 3,397 | - | - | 6,183 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.15% | 0.00% | 563,932 | -73,100 | -11.48% | 1,026,356 | Jun 30, 2024 |
| AVITY INVESTMENT MANAGEMENT INC. | 0.02% | 0.00% | 11,580 | 100 | 0.87% | 21,076 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.01% | 0.00% | 7,000 | - | - | 12,740 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.17% | 0.00% | 83,222 | -4,786 | -5.44% | 151,464 | Jun 30, 2024 |
| WHITTIER TRUST CO OF NEVADA INC | 0.02% | 0.00% | 11,200 | - | - | 20,272 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 15,300 | 3,789 | 32.92% | 27,846 | Jun 30, 2024 |
| RESOURCES INVESTMENT ADVISORS, LLC. | 0.03% | 0.00% | 14,550 | -3,400 | -18.94% | 26,481 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.05% | 0.00% | 24,364 | 24,364 | 100.00% | 44,342 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.02% | 0.00% | 11,384 | 11,384 | 100.00% | 20,719 | Jun 30, 2024 |
The largest Corvus Pharmaceuticals shareholder by % of total assets is ADAMS STREET PARTNERS LLC. The company owns 3.28M shares of Corvus Pharmaceuticals (CRVS), representing 2.46% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 12.16% | 0.03% | 5,964,510 | 5,964,510 | 100.00% | 10,855,408 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 12.49% | 0.19% | 6,123,021 | 3,774,658 | 160.74% | 11,143,898 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.42% | 0.00% | 204,598 | 181,317 | 778.82% | 372,368 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.37% | 0.00% | 1,650,500 | 157,143 | 10.52% | 3,003,910 | Jun 30, 2024 |
| MORGAN STANLEY | 0.76% | 0.00% | 371,403 | 96,042 | 34.88% | 675,954 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.94% | 0.00% | 460,140 | 88,377 | 23.77% | 837,619 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.15% | 0.00% | 74,559 | 74,559 | 100.00% | 135,698 | Jun 30, 2024 |
| BLACKROCK INC. | 1.15% | - | 562,024 | 39,046 | 7.47% | 1,022,884 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.05% | 0.00% | 24,364 | 24,364 | 100.00% | 44,342 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.17% | - | 82,990 | 18,041 | 27.78% | 151,042,000 | Jun 30, 2024 |
| TOWERVIEW LLC | 0.82% | 0.48% | 400,000 | 17,500 | 4.58% | 728,000 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.02% | 0.00% | 11,384 | 11,384 | 100.00% | 20,719 | Jun 30, 2024 |
| UBS GROUP AG | 0.03% | - | 13,000 | 8,321 | 177.84% | 23,660 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 7,238 | 7,238 | 100.00% | 13,000 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 15,300 | 3,789 | 32.92% | 27,846 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 392 | 392 | 100.00% | 713 | Jun 30, 2024 |
| AVITY INVESTMENT MANAGEMENT INC. | 0.02% | 0.00% | 11,580 | 100 | 0.87% | 21,076 | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 53 | 36 | 211.76% | 96 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | 20 | - | - | 36 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 791 | - | - | 1,439 | Jun 30, 2024 |
As of Jun 30 2024, Corvus Pharmaceuticals's largest institutional buyer is POINT72 ASSET MANAGEMENT, L.P.. The company purchased 5.96M stocks of CRVS, valued at $10.86M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -361,406 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.26% | 0.01% | 127,300 | -97,000 | -43.25% | 231,686 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.15% | 0.00% | 563,932 | -73,100 | -11.48% | 1,026,356 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.10% | 0.00% | 47,786 | -54,663 | -53.36% | 86,971 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.02% | - | 9,152 | -43,672 | -82.67% | 16,657 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -12,570 | -100.00% | - | Jun 30, 2024 |
| FORTEM FINANCIAL GROUP, LLC | - | - | - | -11,000 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 2,212 | -7,134 | -76.33% | 4,000 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.17% | 0.00% | 83,222 | -4,786 | -5.44% | 151,464 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -4,604 | -100.00% | - | Jun 30, 2024 |
| RESOURCES INVESTMENT ADVISORS, LLC. | 0.03% | 0.00% | 14,550 | -3,400 | -18.94% | 26,481 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -2,378 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 534 | -666 | -55.50% | 971 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -265 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -165 | -100.00% | - | Jun 30, 2024 |
| ADAMS STREET PARTNERS LLC | 6.68% | 2.46% | 3,275,616 | - | - | 5,961,621 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 14.16% | 0.25% | 6,943,654 | - | - | 12,637,450 | Jun 30, 2024 |
| JACKSON SQUARE CAPITAL, LLC | 0.13% | 0.03% | 63,773 | - | - | 116,067 | Jun 30, 2024 |
| MASSO TORRENCE WEALTH MANAGEMENT INC. | 0.02% | 0.01% | 10,000 | - | - | 18,200 | Jun 30, 2024 |
| HIKARI POWER LTD | 0.10% | 0.01% | 49,959 | - | - | 91,000 | Jun 30, 2024 |
As of Jun 30 2024, Corvus Pharmaceuticals's biggest institutional seller is BVF INC/IL. The company sold -0.36M shares of CRVS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 12.16% | 0.03% | 5,964,510 | 5,964,510 | 100.00% | 10,855,408 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.15% | 0.00% | 74,559 | 74,559 | 100.00% | 135,698 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.05% | 0.00% | 24,364 | 24,364 | 100.00% | 44,342 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.02% | 0.00% | 11,384 | 11,384 | 100.00% | 20,719 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 7,238 | 7,238 | 100.00% | 13,000 | Jun 30, 2024 |
Corvus Pharmaceuticals's largest new institutional shareholder by number of shares is POINT72 ASSET MANAGEMENT, L.P., purchased 5.96M shares, valued at $10.86M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -361,406 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -12,570 | -100.00% | - | Jun 30, 2024 |
| FORTEM FINANCIAL GROUP, LLC | - | - | - | -11,000 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -4,604 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -2,378 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -265 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -165 | -100.00% | - | Jun 30, 2024 |
Corvus Pharmaceuticals's largest sold out institutional shareholder by shares sold is BVF INC/IL, sold -0.36M shares, valued at -, as of undefined.
Corvus Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | 0.12% | 385,331 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.09% | 220,700 | 75,000 | 51.48% | Mar 28, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.09% | 335,956 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 368,971 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 20,935 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 169,989 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 33,425 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,427,524 | -282,672 | -16.53% | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 46,866 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 341,420 | 10,026 | 3.03% | Feb 29, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 20,219 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 29,109 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 1,984 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 15,668 | - | - | Jan 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 1,260 | - | - | Mar 28, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 370 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 18,248 | -214 | -1.16% | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 3,100 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 12,000 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 20,000 | - | - | Feb 29, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 1,065 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 5,735 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 15,617 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 13,232 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 40,167 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 4,000 | -100 | -2.44% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,036 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 3,915 | - | - | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 2,660 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 2,565 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 4,715 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 4,680 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 57,106 | 2,432 | 4.45% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 733 | 580 | 379.08% | Mar 31, 2024 |
Corvus Pharmaceuticals's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 385.33K shares, compromising 0.12% of its total assets.
Corvus Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -58.00% |
| 31 Mar, 24 | 50 | - |
| 31 Dec, 23 | 50 | -10.71% |
| 30 Sep, 23 | 56 | - |
| 30 Jun, 23 | 56 | 51.35% |
| 31 Mar, 23 | 37 | -11.90% |
| 31 Dec, 22 | 42 | 7.69% |
| 30 Sep, 22 | 39 | -13.33% |
| 30 Jun, 22 | 45 | -26.23% |
| 31 Mar, 22 | 61 | -10.29% |
| 31 Dec, 21 | 68 | -5.56% |
| 30 Sep, 21 | 72 | 50.00% |
| 30 Jun, 21 | 48 | -5.88% |
| 31 Mar, 21 | 51 | 37.84% |
| 31 Dec, 20 | 37 | 8.82% |
| 30 Sep, 20 | 34 | -5.56% |
| 30 Jun, 20 | 36 | -2.70% |
| 31 Mar, 20 | 37 | 2.78% |
| 31 Dec, 19 | 36 | 5.88% |
| 30 Sep, 19 | 34 | -20.93% |
| 30 Jun, 19 | 43 | -25.86% |
| 31 Mar, 19 | 58 | -3.33% |
| 31 Dec, 18 | 60 | -1.64% |
| 30 Sep, 18 | 61 | 8.93% |
| 30 Jun, 18 | 56 | 3.70% |
| 31 Mar, 18 | 54 | - |
| 31 Dec, 17 | 54 | 1.89% |
| 30 Sep, 17 | 53 | 8.16% |
| 30 Jun, 17 | 49 | -5.77% |
| 31 Mar, 17 | 52 | -1.89% |
| 31 Dec, 16 | 53 | 20.45% |
| 30 Sep, 16 | 44 | -4.35% |
| 30 Jun, 16 | 46 | 43.75% |
| 31 Mar, 16 | 32 | - |
As of 30 Jun 24, 21 institutions are holding Corvus Pharmaceuticals's shares, representing a decrease of -58.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 1,756,792 | -90.19% |
| 31 Mar, 24 | 17,899,766 | -6.69% |
| 31 Dec, 23 | 19,183,314 | -0.02% |
| 30 Sep, 23 | 19,186,336 | -1.57% |
| 30 Jun, 23 | 19,491,995 | -6.26% |
| 31 Mar, 23 | 20,792,621 | -2.69% |
| 31 Dec, 22 | 21,367,158 | -3.20% |
| 30 Sep, 22 | 22,072,894 | -13.77% |
| 30 Jun, 22 | 25,598,421 | -6.50% |
| 31 Mar, 22 | 27,376,737 | -1.09% |
| 31 Dec, 21 | 27,679,186 | -1.78% |
| 30 Sep, 21 | 28,180,603 | 19.04% |
| 30 Jun, 21 | 23,673,635 | 16.08% |
| 31 Mar, 21 | 20,394,605 | 25.35% |
| 31 Dec, 20 | 16,270,062 | -5.20% |
| 30 Sep, 20 | 17,162,768 | -16.04% |
| 30 Jun, 20 | 20,441,303 | -1.02% |
| 31 Mar, 20 | 20,652,072 | -0.63% |
| 31 Dec, 19 | 20,783,650 | -9.21% |
| 30 Sep, 19 | 22,891,686 | -5.96% |
| 30 Jun, 19 | 24,342,677 | -1.71% |
| 31 Mar, 19 | 24,764,985 | -1.45% |
| 31 Dec, 18 | 25,129,821 | -1.86% |
| 30 Sep, 18 | 25,605,044 | -1.17% |
| 30 Jun, 18 | 25,906,912 | 2.46% |
| 31 Mar, 18 | 25,285,644 | 45.16% |
| 31 Dec, 17 | 17,418,801 | -0.72% |
| 30 Sep, 17 | 17,544,248 | 0.23% |
| 30 Jun, 17 | 17,504,629 | 0.98% |
| 31 Mar, 17 | 17,335,244 | -0.85% |
| 31 Dec, 16 | 17,484,501 | 7.49% |
| 30 Sep, 16 | 16,266,787 | -6.15% |
| 30 Jun, 16 | 17,333,073 | 5.40% |
| 31 Mar, 16 | 16,445,501 | - |
Corvus Pharmaceuticals (CRVS) has 1.76M shares outstanding as of 30 Jun 24, down -90.19% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 3.58% | 0.27% |
| 31 Mar, 24 | 36.50% | 2.38% |
| 31 Dec, 23 | 39.17% | 2.40% |
| 30 Sep, 23 | 40.39% | 2.30% |
| 30 Jun, 23 | 41.87% | 2.10% |
| 31 Mar, 23 | 44.66% | 2.12% |
| 31 Dec, 22 | 45.90% | 2.04% |
| 30 Sep, 22 | 47.41% | 1.57% |
| 30 Jun, 22 | 54.99% | 1.59% |
| 31 Mar, 22 | 58.81% | 1.34% |
| 31 Dec, 21 | 66.13% | 1.61% |
| 30 Sep, 21 | 64.12% | 2.04% |
| 30 Jun, 21 | 56.04% | 1.60% |
| 31 Mar, 21 | 59.09% | 1.95% |
| 31 Dec, 20 | 55.01% | 1.63% |
| 30 Sep, 20 | 58.18% | 1.21% |
| 30 Jun, 20 | 69.46% | 1.41% |
| 31 Mar, 20 | 70.22% | 1.40% |
| 31 Dec, 19 | 70.70% | 1.17% |
| 30 Sep, 19 | 77.89% | 1.13% |
| 30 Jun, 19 | 83.05% | 1.16% |
| 31 Mar, 19 | 84.54% | 1.15% |
| 31 Dec, 18 | 85.92% | 1.11% |
| 30 Sep, 18 | 88.03% | 1.10% |
| 30 Jun, 18 | 89.40% | 0.71% |
| 31 Mar, 18 | 111.98% | 1.55% |
| 31 Dec, 17 | 85.02% | 1.16% |
| 30 Sep, 17 | 85.58% | 1.17% |
| 30 Jun, 17 | 85.69% | 1.18% |
| 31 Mar, 17 | 85.19% | 0.66% |
| 31 Dec, 16 | 113.37% | 1.75% |
| 30 Sep, 16 | 80.59% | 1.07% |
| 30 Jun, 16 | 86.84% | 1.28% |
| 31 Mar, 16 | 82.39% | - |
As of 30 Jun 24, Corvus Pharmaceuticals is held by 3.58% institutional shareholders, representing a 0.27% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -84.21% |
| 31 Mar, 24 | 19 | 35.71% |
| 31 Dec, 23 | 14 | -41.67% |
| 30 Sep, 23 | 24 | -31.43% |
| 30 Jun, 23 | 35 | 250.00% |
| 31 Mar, 23 | 10 | -23.08% |
| 31 Dec, 22 | 13 | 18.18% |
| 30 Sep, 22 | 11 | -26.67% |
| 30 Jun, 22 | 15 | -34.78% |
| 31 Mar, 22 | 23 | -34.29% |
| 31 Dec, 21 | 35 | -5.41% |
| 30 Sep, 21 | 37 | 131.25% |
| 30 Jun, 21 | 16 | -54.29% |
| 31 Mar, 21 | 35 | 150.00% |
| 31 Dec, 20 | 14 | -6.67% |
| 30 Sep, 20 | 15 | 7.14% |
| 30 Jun, 20 | 14 | -26.32% |
| 31 Mar, 20 | 19 | 18.75% |
| 31 Dec, 19 | 16 | -5.88% |
| 30 Sep, 19 | 17 | -10.53% |
| 30 Jun, 19 | 19 | -13.64% |
| 31 Mar, 19 | 22 | -29.03% |
| 31 Dec, 18 | 31 | -8.82% |
| 30 Sep, 18 | 34 | -5.56% |
| 30 Jun, 18 | 36 | 5.88% |
| 31 Mar, 18 | 34 | 17.24% |
| 31 Dec, 17 | 29 | 16.00% |
| 30 Sep, 17 | 25 | -28.57% |
| 30 Jun, 17 | 35 | 34.62% |
| 31 Mar, 17 | 26 | 8.33% |
| 31 Dec, 16 | 24 | 14.29% |
| 30 Sep, 16 | 21 | -40.00% |
| 30 Jun, 16 | 35 | 9.38% |
| 31 Mar, 16 | 32 | - |
3 institutional shareholders have increased their position in CRVS stock as of 30 Jun 24 compared to 19 in the previous quarter (a -84.21% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 5 | -61.54% |
| 31 Mar, 24 | 13 | 18.18% |
| 31 Dec, 23 | 11 | -8.33% |
| 30 Sep, 23 | 12 | 100.00% |
| 30 Jun, 23 | 6 | 20.00% |
| 31 Mar, 23 | 5 | -61.54% |
| 31 Dec, 22 | 13 | 30.00% |
| 30 Sep, 22 | 10 | - |
| 30 Jun, 22 | 10 | -37.50% |
| 31 Mar, 22 | 16 | - |
| 31 Dec, 21 | 16 | - |
| 30 Sep, 21 | 16 | 23.08% |
| 30 Jun, 21 | 13 | 62.50% |
| 31 Mar, 21 | 8 | -33.33% |
| 31 Dec, 20 | 12 | 9.09% |
| 30 Sep, 20 | 11 | 37.50% |
| 30 Jun, 20 | 8 | - |
| 31 Mar, 20 | 8 | -42.86% |
| 31 Dec, 19 | 14 | 40.00% |
| 30 Sep, 19 | 10 | -33.33% |
| 30 Jun, 19 | 15 | -34.78% |
| 31 Mar, 19 | 23 | 53.33% |
| 31 Dec, 18 | 15 | 7.14% |
| 30 Sep, 18 | 14 | 16.67% |
| 30 Jun, 18 | 12 | 33.33% |
| 31 Mar, 18 | 9 | -30.77% |
| 31 Dec, 17 | 13 | -13.33% |
| 30 Sep, 17 | 15 | 114.29% |
| 30 Jun, 17 | 7 | -58.82% |
| 31 Mar, 17 | 17 | 6.25% |
| 31 Dec, 16 | 16 | 60.00% |
| 30 Sep, 16 | 10 | 42.86% |
| 30 Jun, 16 | 7 | - |
| 31 Mar, 16 | - | - |
5 institutional shareholders have reduced their position in CRVS stock as of 30 Jun 24 compared to 13 in the previous quarter (a -61.54% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 21 | -58.00% | 1,756,792 | -90.19% | 3.58% | 0.27% | 3 | -84.21% | 5 | -61.54% |
| 31 Mar, 24 | 50 | - | 17,899,766 | -6.69% | 36.50% | 2.38% | 19 | 35.71% | 13 | 18.18% |
| 31 Dec, 23 | 50 | -10.71% | 19,183,314 | -0.02% | 39.17% | 2.40% | 14 | -41.67% | 11 | -8.33% |
| 30 Sep, 23 | 56 | - | 19,186,336 | -1.57% | 40.39% | 2.30% | 24 | -31.43% | 12 | 100.00% |
| 30 Jun, 23 | 56 | 51.35% | 19,491,995 | -6.26% | 41.87% | 2.10% | 35 | 250.00% | 6 | 20.00% |
| 31 Mar, 23 | 37 | -11.90% | 20,792,621 | -2.69% | 44.66% | 2.12% | 10 | -23.08% | 5 | -61.54% |
| 31 Dec, 22 | 42 | 7.69% | 21,367,158 | -3.20% | 45.90% | 2.04% | 13 | 18.18% | 13 | 30.00% |
| 30 Sep, 22 | 39 | -13.33% | 22,072,894 | -13.77% | 47.41% | 1.57% | 11 | -26.67% | 10 | - |
| 30 Jun, 22 | 45 | -26.23% | 25,598,421 | -6.50% | 54.99% | 1.59% | 15 | -34.78% | 10 | -37.50% |
| 31 Mar, 22 | 61 | -10.29% | 27,376,737 | -1.09% | 58.81% | 1.34% | 23 | -34.29% | 16 | - |
| 31 Dec, 21 | 68 | -5.56% | 27,679,186 | -1.78% | 66.13% | 1.61% | 35 | -5.41% | 16 | - |
| 30 Sep, 21 | 72 | 50.00% | 28,180,603 | 19.04% | 64.12% | 2.04% | 37 | 131.25% | 16 | 23.08% |
| 30 Jun, 21 | 48 | -5.88% | 23,673,635 | 16.08% | 56.04% | 1.60% | 16 | -54.29% | 13 | 62.50% |
| 31 Mar, 21 | 51 | 37.84% | 20,394,605 | 25.35% | 59.09% | 1.95% | 35 | 150.00% | 8 | -33.33% |
| 31 Dec, 20 | 37 | 8.82% | 16,270,062 | -5.20% | 55.01% | 1.63% | 14 | -6.67% | 12 | 9.09% |
| 30 Sep, 20 | 34 | -5.56% | 17,162,768 | -16.04% | 58.18% | 1.21% | 15 | 7.14% | 11 | 37.50% |
| 30 Jun, 20 | 36 | -2.70% | 20,441,303 | -1.02% | 69.46% | 1.41% | 14 | -26.32% | 8 | - |
| 31 Mar, 20 | 37 | 2.78% | 20,652,072 | -0.63% | 70.22% | 1.40% | 19 | 18.75% | 8 | -42.86% |
| 31 Dec, 19 | 36 | 5.88% | 20,783,650 | -9.21% | 70.70% | 1.17% | 16 | -5.88% | 14 | 40.00% |
| 30 Sep, 19 | 34 | -20.93% | 22,891,686 | -5.96% | 77.89% | 1.13% | 17 | -10.53% | 10 | -33.33% |
| 30 Jun, 19 | 43 | -25.86% | 24,342,677 | -1.71% | 83.05% | 1.16% | 19 | -13.64% | 15 | -34.78% |
| 31 Mar, 19 | 58 | -3.33% | 24,764,985 | -1.45% | 84.54% | 1.15% | 22 | -29.03% | 23 | 53.33% |
| 31 Dec, 18 | 60 | -1.64% | 25,129,821 | -1.86% | 85.92% | 1.11% | 31 | -8.82% | 15 | 7.14% |
| 30 Sep, 18 | 61 | 8.93% | 25,605,044 | -1.17% | 88.03% | 1.10% | 34 | -5.56% | 14 | 16.67% |
| 30 Jun, 18 | 56 | 3.70% | 25,906,912 | 2.46% | 89.40% | 0.71% | 36 | 5.88% | 12 | 33.33% |
| 31 Mar, 18 | 54 | - | 25,285,644 | 45.16% | 111.98% | 1.55% | 34 | 17.24% | 9 | -30.77% |
| 31 Dec, 17 | 54 | 1.89% | 17,418,801 | -0.72% | 85.02% | 1.16% | 29 | 16.00% | 13 | -13.33% |
| 30 Sep, 17 | 53 | 8.16% | 17,544,248 | 0.23% | 85.58% | 1.17% | 25 | -28.57% | 15 | 114.29% |
| 30 Jun, 17 | 49 | -5.77% | 17,504,629 | 0.98% | 85.69% | 1.18% | 35 | 34.62% | 7 | -58.82% |
| 31 Mar, 17 | 52 | -1.89% | 17,335,244 | -0.85% | 85.19% | 0.66% | 26 | 8.33% | 17 | 6.25% |
| 31 Dec, 16 | 53 | 20.45% | 17,484,501 | 7.49% | 113.37% | 1.75% | 24 | 14.29% | 16 | 60.00% |
| 30 Sep, 16 | 44 | -4.35% | 16,266,787 | -6.15% | 80.59% | 1.07% | 21 | -40.00% | 10 | 42.86% |
| 30 Jun, 16 | 46 | 43.75% | 17,333,073 | 5.40% | 86.84% | 1.28% | 35 | 9.38% | 7 | - |
| 31 Mar, 16 | 32 | - | 16,445,501 | - | 82.39% | - | 32 | - | - | - |
Corvus Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Corvus Pharmaceuticals's stock was made by MILLER RICHARD A MD on May 14 2024, selling 302,016 shares at - per share (valued at -). The last insider buy of CRVS was made by Thompson Peter A. on May 08 2024, buying 1,444,085 shares at - per share (worth $144.41).
Corvus Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 8 | - | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | 9 | - | - |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 1 | - | - |
| Q4 2022 | 5 | - | - |
| Q3 2022 | 20 | - | - |
| Q2 2022 | 14 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | - | 1 | - |
| Q3 2021 | 11 | 3 | 366.67% |
| Q2 2021 | 8 | - | - |
| Q1 2021 | 3 | - | - |
| Q4 2020 | 4 | - | - |
| Q3 2020 | 1 | 2 | 50.00% |
| Q2 2020 | 7 | 1 | 700.00% |
| Q1 2020 | 7 | - | - |
| Q4 2019 | 9 | - | - |
| Q3 2019 | 6 | 3 | 200.00% |
| Q2 2019 | 17 | - | - |
8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Corvus Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 8 | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q2 2023 | 1 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 5 | - | - |
| Q3 2022 | 4 | - | - |
| Q2 2022 | 5 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | - | 1 | - |
| Q3 2021 | 1 | 3 | 33.33% |
| Q2 2021 | 1 | - | - |
| Q1 2021 | 3 | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | 2 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 6 | 3 | 200.00% |
| Q2 2019 | 10 | - | - |
As of Q2 2024, Insider owners conducted 8 open market buy trades and 0 open market sell trades of Corvus Pharmaceuticals's stocks.
CRVS Ownership FAQ
Who Owns Corvus Pharmaceuticals?
Corvus Pharmaceuticals is owned by institutional shareholders (3.58%), insiders (4.02%), and public (92.40%). The largest institutional shareholder of Corvus Pharmaceuticals is ORBIMED ADVISORS LLC (14.16% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.12% of total shares).
Who are the major institutional shareholders of Corvus Pharmaceuticals?
Corvus Pharmaceuticals's major institutional shareholders are ORBIMED ADVISORS LLC, SAMLYN CAPITAL, LLC, POINT72 ASSET MANAGEMENT, L.P., ADAMS STREET PARTNERS LLC, and VANGUARD GROUP INC. The top five shareholders own together 48.85% of the company's share outstanding.
How many Corvus Pharmaceuticals shareholders are there?
As of Jun 2024, there are 21 institutional shareholders of Corvus Pharmaceuticals.
What percentage of Corvus Pharmaceuticals is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC owns 6.94M shares of Corvus Pharmaceuticals, representing 14.16% of the company's total shares outstanding, valued at $12.64M (as of Jun 2024).
What percentage of Corvus Pharmaceuticals is owned by SAMLYN CAPITAL, LLC?
As of Jun 2024, SAMLYN CAPITAL, LLC holds 6.12M shares of Corvus Pharmaceuticals (CRVS), compromising 12.49% of the company, valued at $11.14M.
What percentage of Corvus Pharmaceuticals is owned by POINT72 ASSET MANAGEMENT, L.P?
POINT72 ASSET MANAGEMENT, L.P is the third largest holder of Corvus Pharmaceuticals. The company owns 5.96M of the company's shares outstanding (worth $10.86M).